Cargando…

Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties

This article presents the outcomes of higher-tier repeated-dose toxicity studies and developmental and reproductive toxicity (DART) studies using Wistar rats requested for methyl paraben and propyl paraben under the European Union chemicals legislation. All studies revealed no-observed adverse effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fayyaz, Susann, Kreiling, Reinhard, Sauer, Ursula G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904550/
https://www.ncbi.nlm.nih.gov/pubmed/33459807
http://dx.doi.org/10.1007/s00204-020-02967-0
_version_ 1783654955183243264
author Fayyaz, Susann
Kreiling, Reinhard
Sauer, Ursula G.
author_facet Fayyaz, Susann
Kreiling, Reinhard
Sauer, Ursula G.
author_sort Fayyaz, Susann
collection PubMed
description This article presents the outcomes of higher-tier repeated-dose toxicity studies and developmental and reproductive toxicity (DART) studies using Wistar rats requested for methyl paraben and propyl paraben under the European Union chemicals legislation. All studies revealed no-observed adverse effects (NOAELs) at 1000 mg/kg body weight/day. These findings (absence of effects) were then used to interpolate the hazard profile for ethyl paraben, further considering available data for butyl paraben. The underlying read-across hypothesis (all shorter-chained linear n-alkyl parabens are a ‘category’ based on very high structural similarity and are transformed to a common compound) was confirmed by similarity calculations and comparative in vivo toxicokinetics screening studies for methyl paraben, ethyl paraben, propyl paraben and butyl paraben. All four parabens were rapidly taken up systemically following oral gavage administration to rats, metabolised to p-hydroxybenzoic acid, and rapidly eliminated (parabens within one hour; p-hydroxybenzoic acid within 4–8 h). Accordingly, for ethyl paraben, the NOAELs for repeated-dose toxicity and DART were interpolated to be 1000 mg/kg body weight/day. Finally, all evidence was evaluated to address concerns expressed in the literature that parabens might be endocrine disruptors. This evaluation showed that the higher-tier studies do not provide any indication for any endocrine disrupting property. This is the first time that a comprehensive dataset from higher-tier in vivo studies following internationally agreed test protocols has become available for shorter-chained linear n-alkyl parabens. Consistently, the dataset shows that these parabens are devoid of repeated-dose toxicity and do not possess any DART or endocrine disrupting properties. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-020-02967-0.
format Online
Article
Text
id pubmed-7904550
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-79045502021-03-09 Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties Fayyaz, Susann Kreiling, Reinhard Sauer, Ursula G. Arch Toxicol Regulatory Toxicology This article presents the outcomes of higher-tier repeated-dose toxicity studies and developmental and reproductive toxicity (DART) studies using Wistar rats requested for methyl paraben and propyl paraben under the European Union chemicals legislation. All studies revealed no-observed adverse effects (NOAELs) at 1000 mg/kg body weight/day. These findings (absence of effects) were then used to interpolate the hazard profile for ethyl paraben, further considering available data for butyl paraben. The underlying read-across hypothesis (all shorter-chained linear n-alkyl parabens are a ‘category’ based on very high structural similarity and are transformed to a common compound) was confirmed by similarity calculations and comparative in vivo toxicokinetics screening studies for methyl paraben, ethyl paraben, propyl paraben and butyl paraben. All four parabens were rapidly taken up systemically following oral gavage administration to rats, metabolised to p-hydroxybenzoic acid, and rapidly eliminated (parabens within one hour; p-hydroxybenzoic acid within 4–8 h). Accordingly, for ethyl paraben, the NOAELs for repeated-dose toxicity and DART were interpolated to be 1000 mg/kg body weight/day. Finally, all evidence was evaluated to address concerns expressed in the literature that parabens might be endocrine disruptors. This evaluation showed that the higher-tier studies do not provide any indication for any endocrine disrupting property. This is the first time that a comprehensive dataset from higher-tier in vivo studies following internationally agreed test protocols has become available for shorter-chained linear n-alkyl parabens. Consistently, the dataset shows that these parabens are devoid of repeated-dose toxicity and do not possess any DART or endocrine disrupting properties. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00204-020-02967-0. Springer Berlin Heidelberg 2021-01-18 2021 /pmc/articles/PMC7904550/ /pubmed/33459807 http://dx.doi.org/10.1007/s00204-020-02967-0 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Regulatory Toxicology
Fayyaz, Susann
Kreiling, Reinhard
Sauer, Ursula G.
Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
title Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
title_full Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
title_fullStr Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
title_full_unstemmed Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
title_short Application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
title_sort application of grouping and read-across for the evaluation of parabens of different chain lengths with a particular focus on endocrine properties
topic Regulatory Toxicology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904550/
https://www.ncbi.nlm.nih.gov/pubmed/33459807
http://dx.doi.org/10.1007/s00204-020-02967-0
work_keys_str_mv AT fayyazsusann applicationofgroupingandreadacrossfortheevaluationofparabensofdifferentchainlengthswithaparticularfocusonendocrineproperties
AT kreilingreinhard applicationofgroupingandreadacrossfortheevaluationofparabensofdifferentchainlengthswithaparticularfocusonendocrineproperties
AT sauerursulag applicationofgroupingandreadacrossfortheevaluationofparabensofdifferentchainlengthswithaparticularfocusonendocrineproperties